Skip to main content
. 2014 Nov 12;2(4):E201–E206. doi: 10.1055/s-0034-1377522

Table 2. Characteristics of patients with established Crohn’s disease.

Variable (n = 43) Number (%)
Extent of CD Small-bowel CD Ileo-colonic CD Ileo-colonic and duodenum CD 14 (32.6)26 (60.5) 3 (6.9)
Phenotype of CD Stricturing CD Fistulizing CD 32 (74.4)11 (25.6)
5-Aminosalicylate use 10 (23.3)
Corticosteroid use 17 (39.5)
Azathioprine/6-mercaptopurine use 12 (27.9)
Biologics use 20 (46.5)
Duration of CD, median (range), y  8 (1 – 14)

CD, Crohn’s disease.